Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Cowin Biotech (CWBIO) is a prominent Chinese biotechnology company specializing in the development and manufacture of molecular biology reagents and diagnostic solutions. Founded in 2010 and headquartered in the China Medical City of Taizhou, the company has established a comprehensive technology platform covering nucleic acid preservation, extraction, and amplification. Cowin Biotech's product portfolio includes high-quality reagents for PCR, NGS library preparation, and molecular diagnostic kits for infectious diseases and oncology. The company is publicly listed on the Shanghai Stock Exchange's STAR Market and serves a global clientele across research, clinical, and industrial sectors. Its core mission focuses on advancing precision medicine through innovative molecular toolsets and diagnostic technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Healthy Life.